Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022

Author: Benzinga Insights | September 09, 2022 10:40am

Upgrades

For 3M Co (NYSE:MMM), UBS upgraded the previous rating of Sell to Neutral. For the second quarter, 3M had an EPS of $2.48, compared to year-ago quarter EPS of $2.59. The current stock performance of 3M shows a 52-week-high of $181.78 and a 52-week-low of $115.98. Moreover, at the end of the last trading period, the closing price was at $119.27.

Daiwa Capital upgraded the previous rating for Coinbase Global Inc (NASDAQ:COIN) from Outperform to Buy. Coinbase Global earned $4.98 in the second quarter, compared to $6.42 in the year-ago quarter. At the moment, the stock has a 52-week-high of $258.81 and a 52-week-low of $40.83. Coinbase Global closed at $73.08 at the end of the last trading period.

According to Morgan Stanley, the prior rating for Ionis Pharmaceuticals Inc (NASDAQ:IONS) was changed from Underweight to Overweight. Ionis Pharmaceuticals earned $0.56 in the second quarter, compared to $0.26 in the year-ago quarter. The current stock performance of Ionis Pharmaceuticals shows a 52-week-high of $46.15 and a 52-week-low of $28.25. Moreover, at the end of the last trading period, the closing price was at $44.27.

According to B of A Securities, the prior rating for Elevance Health Inc (NYSE:ELV) was changed from Neutral to Buy. Elevance Health earned $8.04 in the second quarter, compared to $7.03 in the year-ago quarter. NoneThe current stock performance of Elevance Health shows a 52-week-high of $512.99 and a 52-week-low of $451.37. Moreover, at the end of the last trading period, the closing price was at $489.35.

For Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the second quarter, Regeneron Pharmaceuticals showed an EPS of $9.77, compared to $25.80 from the year-ago quarter. The stock has a 52-week-high of $747.42 and a 52-week-low of $538.01. At the end of the last trading period, Regeneron Pharmaceuticals closed at $708.85.

Morgan Stanley upgraded the previous rating for Hudson Pacific Properties Inc (NYSE:HPP) from Underweight to Equal-Weight. In the second quarter, Hudson Pacific Properties showed an EPS of $0.51, compared to $0.49 from the year-ago quarter. The stock has a 52-week-high of $28.66 and a 52-week-low of $12.73. At the end of the last trading period, Hudson Pacific Properties closed at $14.14.

Needham upgraded the previous rating for Penumbra Inc (NYSE:PEN) from Hold to Buy. For the second quarter, Penumbra had an EPS of $0.01, compared to year-ago quarter EPS of $0.21. The current stock performance of Penumbra shows a 52-week-high of $287.53 and a 52-week-low of $114.86. Moreover, at the end of the last trading period, the closing price was at $197.49.

According to Jefferies, the prior rating for Regeneron Pharmaceuticals Inc (NASDAQ:REGN) was changed from Underperform to Hold. For the second quarter, Regeneron Pharmaceuticals had an EPS of $9.77, compared to year-ago quarter EPS of $25.80. The current stock performance of Regeneron Pharmaceuticals shows a 52-week-high of $747.42 and a 52-week-low of $538.01. Moreover, at the end of the last trading period, the closing price was at $708.85.

According to JP Morgan, the prior rating for Spire Inc (NYSE:SR) was changed from Neutral to Overweight. For the third quarter, Spire had an EPS of $0.01, compared to year-ago quarter EPS of $0.06. The current stock performance of Spire shows a 52-week-high of $79.24 and a 52-week-low of $61.89. Moreover, at the end of the last trading period, the closing price was at $69.59.

JP Morgan upgraded the previous rating for American Water Works Co Inc (NYSE:AWK) from Underweight to Neutral. American Water Works earned $1.20 in the second quarter, compared to $1.14 in the year-ago quarter. NoneThe current stock performance of American Water Works shows a 52-week-high of $189.25 and a 52-week-low of $129.45. Moreover, at the end of the last trading period, the closing price was at $154.52.

See all analyst ratings upgrades.

Downgrades

Cleveland Research downgraded the previous rating for Avantor Inc (NYSE:AVTR) from Buy to Neutral. For the second quarter, Avantor had an EPS of $0.37, compared to year-ago quarter EPS of $0.35. At the moment, the stock has a 52-week-high of $41.98 and a 52-week-low of $24.32. Avantor closed at $25.87 at the end of the last trading period.

For Essential Utilities Inc (NYSE:WTRG), B of A Securities downgraded the previous rating of Buy to Neutral. Essential Utilities earned $0.31 in the second quarter, compared to $0.32 in the year-ago quarter. The current stock performance of Essential Utilities shows a 52-week-high of $53.66 and a 52-week-low of $40.97. Moreover, at the end of the last trading period, the closing price was at $48.66.

For Zumiez Inc (NASDAQ:ZUMZ), William Blair downgraded the previous rating of Outperform to Market Perform. In the second quarter, Zumiez showed an EPS of $0.16, compared to $0.94 from the year-ago quarter. The stock has a 52-week-high of $49.98 and a 52-week-low of $24.02. At the end of the last trading period, Zumiez closed at $26.54.

According to Guggenheim, the prior rating for Enphase Energy Inc (NASDAQ:ENPH) was changed from Buy to Neutral. In the second quarter, Enphase Energy showed an EPS of $1.07, compared to $0.53 from the year-ago quarter. The current stock performance of Enphase Energy shows a 52-week-high of $324.84 and a 52-week-low of $113.40. Moreover, at the end of the last trading period, the closing price was at $317.41.

For Shoals Technologies Group Inc (NASDAQ:SHLS), Guggenheim downgraded the previous rating of Buy to Neutral. For the second quarter, Shoals Technologies Gr had an EPS of $0.07, compared to year-ago quarter EPS of $0.09. The current stock performance of Shoals Technologies Gr shows a 52-week-high of $28.47 and a 52-week-low of $9.58. Moreover, at the end of the last trading period, the closing price was at $27.60.

For Sonic Automotive Inc (NYSE:SAH), B of A Securities downgraded the previous rating of Buy to Underperform. Sonic Automotive earned $2.45 in the second quarter, compared to $2.63 in the year-ago quarter. At the moment, the stock has a 52-week-high of $59.19 and a 52-week-low of $34.17. Sonic Automotive closed at $47.83 at the end of the last trading period.

For CarMax Inc (NYSE:KMX), B of A Securities downgraded the previous rating of Neutral to Underperform. For the first quarter, CarMax had an EPS of $1.56, compared to year-ago quarter EPS of $2.63. The stock has a 52-week-high of $130.57 and a 52-week-low of $84.37. At the end of the last trading period, CarMax closed at $88.88.

For American Axle & Mfg Holdings Inc (NYSE:AXL), B of A Securities downgraded the previous rating of Buy to Neutral. In the second quarter, American Axle & Mfg Hldgs showed an EPS of $0.22, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.96 and a 52-week-low of $6.36. American Axle & Mfg Hldgs closed at $9.87 at the end of the last trading period.

For Navient Corp (NASDAQ:NAVI), Barclays downgraded the previous rating of Overweight to Equal-Weight. For the second quarter, Navient had an EPS of $0.92, compared to year-ago quarter EPS of $0.98. The current stock performance of Navient shows a 52-week-high of $22.59 and a 52-week-low of $12.45. Moreover, at the end of the last trading period, the closing price was at $15.01.

According to Morgan Stanley, the prior rating for Galapagos NV (NASDAQ:GLPG) was changed from Overweight to Equal-Weight. Galapagos earned $0.31 in the second quarter, compared to $1.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $72.11 and a 52-week-low of $47.88. Galapagos closed at $48.57 at the end of the last trading period.

For Prelude Therapeutics Inc (NASDAQ:PRLD), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. For the second quarter, Prelude Therapeutics had an EPS of $0.58, compared to year-ago quarter EPS of $0.58. The current stock performance of Prelude Therapeutics shows a 52-week-high of $13.40 and a 52-week-low of $3.87. Moreover, at the end of the last trading period, the closing price was at $7.94.

Morgan Stanley downgraded the previous rating for Cyteir Therapeutics Inc (NASDAQ:CYT) from Overweight to Equal-Weight. For the second quarter, Cyteir Therapeutics had an EPS of $0.34, compared to year-ago quarter EPS of $4.83. The stock has a 52-week-high of $11.62 and a 52-week-low of $1.55. At the end of the last trading period, Cyteir Therapeutics closed at $2.15.

For Alector Inc (NASDAQ:ALEC), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. In the second quarter, Alector showed an EPS of $0.12, compared to $0.69 from the year-ago quarter. The current stock performance of Alector shows a 52-week-high of $21.25 and a 52-week-low of $7.50. Moreover, at the end of the last trading period, the closing price was at $10.99.

BTIG downgraded the previous rating for New Fortress Energy Inc (NASDAQ:NFE) from Buy to Neutral. New Fortress Energy earned $0.69 in the second quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $63.06 and a 52-week-low of $19.17. At the end of the last trading period, New Fortress Energy closed at $58.79.

Morgan Stanley downgraded the previous rating for ADC Therapeutics SA (NYSE:ADCT) from Overweight to Equal-Weight. In the second quarter, ADC Therapeutics showed an EPS of $0.73, compared to $0.70 from the year-ago quarter. At the moment, the stock has a 52-week-high of $20.67 and a 52-week-low of $5.52. ADC Therapeutics closed at $6.52 at the end of the last trading period.

B. Riley Securities downgraded the previous rating for Zumiez Inc (NASDAQ:ZUMZ) from Buy to Neutral. In the second quarter, Zumiez showed an EPS of $0.16, compared to $0.94 from the year-ago quarter. At the moment, the stock has a 52-week-high of $49.98 and a 52-week-low of $24.02. Zumiez closed at $26.54 at the end of the last trading period.

For Virgin Galactic Holdings Inc (NYSE:SPCE), Bernstein downgraded the previous rating of Market Perform to Underperform. For the second quarter, Virgin Galactic Hldgs had an EPS of $0.43, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $13.73 and a 52-week-low of $5.14. Virgin Galactic Hldgs closed at $6.28 at the end of the last trading period.

JP Morgan downgraded the previous rating for New Jersey Resources Corp (NYSE:NJR) from Neutral to Underweight. New Jersey Resources earned $0.04 in the third quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.50 and a 52-week-low of $37.79. New Jersey Resources closed at $45.64 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

With a Buy rating, DA Davidson initiated coverage on CF Acquisition Corp VI (NASDAQ:CFVI). The price target seems to have been set at $12.00 for CF Acquisition. The stock has a 52-week-high of $18.52 and a 52-week-low of $9.93. At the end of the last trading period, CF Acquisition closed at $12.27.

Loop Capital initiated coverage on Academy Sports and Outdoors Inc (NASDAQ:ASO) with a Buy rating. The price target for Academy Sports is set to $60.00. Academy Sports earned $2.30 in the second quarter, compared to $2.34 in the year-ago quarter. The current stock performance of Academy Sports shows a 52-week-high of $50.00 and a 52-week-low of $25.10. Moreover, at the end of the last trading period, the closing price was at $48.28.

BTIG initiated coverage on Annexon Inc (NASDAQ:ANNX) with a Buy rating. The price target for Annexon is set to $15.00. Annexon earned $0.96 in the second quarter, compared to $0.82 in the year-ago quarter. The current stock performance of Annexon shows a 52-week-high of $11.95 and a 52-week-low of $2.06. Moreover, at the end of the last trading period, the closing price was at $6.02.

For Polestar Automotive Holding UK PLC (NASDAQ:PSNY), Redburn Partners initiated coverage, by setting the current rating at Sell. The stock has a 52-week-high of $13.36 and a 52-week-low of $6.17. At the end of the last trading period, Polestar Automotive closed at $6.72.

With a Buy rating, Canaccord Genuity initiated coverage on Rubicon Technologies Inc (NYSE:RBT). The price target seems to have been set at $10.00 for Rubicon Technologies. The stock has a 52-week-high of $7.94 and a 52-week-low of $3.54. At the end of the last trading period, Rubicon Technologies closed at $3.91.

Credit Suisse initiated coverage on Frontier Communications Parent Inc (NASDAQ:FYBR) with a Neutral rating. The price target for Frontier Communications is set to $25.00. The current stock performance of Frontier Communications shows a 52-week-high of $31.86 and a 52-week-low of $21.93. Moreover, at the end of the last trading period, the closing price was at $26.99.

Morgan Stanley initiated coverage on Vir Biotechnology Inc (NASDAQ:VIR) with an Underweight rating. The price target for Vir Biotechnology is set to $15.00. Vir Biotechnology earned $0.58 in the second quarter, compared to $0.46 in the year-ago quarter. At the moment, the stock has a 52-week-high of $41.85 and a 52-week-low of $18.21. Vir Biotechnology closed at $22.26 at the end of the last trading period.

With a Equal-Weight rating, Morgan Stanley initiated coverage on PTC Therapeutics Inc (NASDAQ:PTCT). The price target seems to have been set at $54.00 for PTC Therapeutics. PTC Therapeutics earned $2.13 in the second quarter, compared to $1.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $54.69 and a 52-week-low of $25.01. PTC Therapeutics closed at $53.85 at the end of the last trading period.

Morgan Stanley initiated coverage on Immunocore Holdings PLC (NASDAQ:IMCR) with an Overweight rating. The price target for Immunocore Hldgs is set to $77.00. Immunocore Hldgs earned $0.17 in the second quarter, compared to $1.45 in the year-ago quarter. The stock has a 52-week-high of $57.44 and a 52-week-low of $18.43. At the end of the last trading period, Immunocore Hldgs closed at $57.44.

Morgan Stanley initiated coverage on Halozyme Therapeutics Inc (NASDAQ:HALO) with an Overweight rating. The price target for Halozyme Therapeutics is set to $50.00. Halozyme Therapeutics earned $0.53 in the second quarter, compared to $0.66 in the year-ago quarter. The current stock performance of Halozyme Therapeutics shows a 52-week-high of $52.98 and a 52-week-low of $31.36. Moreover, at the end of the last trading period, the closing price was at $39.67.

With a Equal-Weight rating, Morgan Stanley initiated coverage on Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR). The price target seems to have been set at $41.00 for Arrowhead Pharmaceuticals. For the third quarter, Arrowhead Pharmaceuticals had an EPS of $0.68, compared to year-ago quarter EPS of $0.29. At the moment, the stock has a 52-week-high of $70.09 and a 52-week-low of $26.81. Arrowhead Pharmaceuticals closed at $39.17 at the end of the last trading period.

Raymond James initiated coverage on V2X Inc (NYSE:VVX) with a Strong Buy rating. The price target for V2X is set to $50.00. The current stock performance of V2X shows a 52-week-high of $41.25 and a 52-week-low of $29.55. Moreover, at the end of the last trading period, the closing price was at $33.88.

Morgan Stanley initiated coverage on Amicus Therapeutics Inc (NASDAQ:FOLD) with a Equal-Weight rating. The price target for Amicus Therapeutics is set to $14.00. For the second quarter, Amicus Therapeutics had an EPS of $0.21, compared to year-ago quarter EPS of $0.19. The stock has a 52-week-high of $12.96 and a 52-week-low of $5.91. At the end of the last trading period, Amicus Therapeutics closed at $11.70.

With an Overweight rating, Barclays initiated coverage on Immunogen Inc (NASDAQ:IMGN). The price target seems to have been set at $8.00 for Immunogen. For the second quarter, Immunogen had an EPS of $0.24, compared to year-ago quarter EPS of $0.15. The stock has a 52-week-high of $7.63 and a 52-week-low of $3.10. At the end of the last trading period, Immunogen closed at $5.46.

B of A Securities initiated coverage on Omnicell Inc (NASDAQ:OMCL) with a Buy rating. The price target for Omnicell is set to $120.00. For the second quarter, Omnicell had an EPS of $0.84, compared to year-ago quarter EPS of $0.97. The current stock performance of Omnicell shows a 52-week-high of $182.77 and a 52-week-low of $98.50. Moreover, at the end of the last trading period, the closing price was at $101.82.

Seaport Global initiated coverage on SoFi Technologies Inc (NASDAQ:SOFI) with a Neutral rating. In the second quarter, SoFi Technologies showed an EPS of $0.12, compared to $0.48 from the year-ago quarter. The current stock performance of SoFi Technologies shows a 52-week-high of $16.47 and a 52-week-low of $4.82. Moreover, at the end of the last trading period, the closing price was at $6.19.

Barclays initiated coverage on Arvinas Inc (NASDAQ:ARVN) with an Overweight rating. The price target for Arvinas is set to $90.00. For the second quarter, Arvinas had an EPS of $1.32, compared to year-ago quarter EPS of $1.03. At the moment, the stock has a 52-week-high of $82.86 and a 52-week-low of $34.90. Arvinas closed at $48.42 at the end of the last trading period.

UBS initiated coverage on Horizon Technology Finance Corp (NASDAQ:HRZN) with a Neutral rating. The price target for Horizon Tech Finance is set to $12.50. In the second quarter, Horizon Tech Finance showed an EPS of $0.35, compared to $0.31 from the year-ago quarter. The current stock performance of Horizon Tech Finance shows a 52-week-high of $16.54 and a 52-week-low of $10.55. Moreover, at the end of the last trading period, the closing price was at $12.27.

Baird initiated coverage on Swvl Holdings Corp (NASDAQ:SWVL) with an Outperform rating. The price target for Swvl Hldgs is set to $8.00. NoneThe current stock performance of Swvl Hldgs shows a 52-week-high of $11.40 and a 52-week-low of $1.42. Moreover, at the end of the last trading period, the closing price was at $1.54.

With a Neutral rating, Rosenblatt initiated coverage on Brightcove Inc (NASDAQ:BCOV). The price target seems to have been set at $8.00 for Brightcove. In the second quarter, Brightcove showed an EPS of $0.10, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $10.52 and a 52-week-low of $5.84. Brightcove closed at $6.75 at the end of the last trading period.

With a Buy rating, Rosenblatt initiated coverage on Lincoln Educational Services Corp (NASDAQ:LINC). The price target seems to have been set at $8.00 for Lincoln Educational Servs. In the second quarter, Lincoln Educational Servs showed an EPS of $0.00, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $7.95 and a 52-week-low of $4.94. At the end of the last trading period, Lincoln Educational Servs closed at $6.48.

Rosenblatt initiated coverage on Quotient Technology Inc (NYSE:QUOT) with a Neutral rating. The price target for Quotient Technology is set to $3.50. In the second quarter, Quotient Technology showed an EPS of $0.45, compared to $0.18 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.92 and a 52-week-low of $1.68. Quotient Technology closed at $1.85 at the end of the last trading period.

Piper Sandler initiated coverage on Inter Parfums Inc (NASDAQ:IPAR) with an Overweight rating. The price target for Inter Parfums is set to $102.00. For the second quarter, Inter Parfums had an EPS of $0.86, compared to year-ago quarter EPS of $0.71. The stock has a 52-week-high of $108.35 and a 52-week-low of $64.52. At the end of the last trading period, Inter Parfums closed at $78.30.

With a Hold rating, Jefferies initiated coverage on Progress Software Corp (NASDAQ:PRGS). The price target seems to have been set at $52.00 for Progress Software. For the second quarter, Progress Software had an EPS of $1.04, compared to year-ago quarter EPS of $0.82. The stock has a 52-week-high of $51.77 and a 52-week-low of $41.68. At the end of the last trading period, Progress Software closed at $46.67.

With a Buy rating, DA Davidson initiated coverage on Waldencast PLC (NASDAQ:WALD). The price target seems to have been set at $12.00 for Waldencast. The current stock performance of Waldencast shows a 52-week-high of $10.89 and a 52-week-low of $6.56. Moreover, at the end of the last trading period, the closing price was at $8.60.

See all analyst ratings initiations.

Posted In: ADCT ALEC ANNX ARVN ARWR ASO AVTR AWK AXL BCOV CFVI COIN CYT ELV ENPH FOLD FYBR GLPG HALO HPP